• sickle cell blood cell

    Gene Editing Study Reveals Possible "Achilles Heel" of Sickle Cell Disease

    Dana-Farber/Boston Children's researchers found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease.
    Car t-cell image

    Immunotherapy Clinical Trial for Relapsed Leukemia

    Dana-Farber/Boston Children's is the first and only site in New England to offer a breakthrough immunotherapy clinical trial for children with relapsed or treatment-resistant acute lymphoblastic leukemia.
    David Williams, MD

    Unlocking the Secrets of Pediatric Cancers can Help Children and Adults

    Understanding cancers of young children could also hold the key to understanding a broad range of adult cancers, David Williams, MD, writes.

    Palliative Care Eases the Burden of Serious Illness

    Pediatric palliative care helps maximize quality of life for children with serious life-threatening or life-limiting illness.
    Gene Therapy Study

    Gene Therapy for “Bubble Boy” Disease Appears Effective, Safe

    A new form of gene therapy for boys with “bubble boy” disease appears to be effective and may avoid the late-developing leukemia seen in patients in pioneering gene therapy trials in Europe more than a decade ago.
  • Ranked #1 for Cancer Care

    US News

    Rated the top pediatric
    cancer center by U.S. News & World Report

  • Why Choose Us?

    Not only are we a top cancer and blood disease center, we're also a top pediatric hospital. Above, our physicians explain how our vast clinical resources benefit patients.